Machine Learning in Medicine - a Complete Overview /

Detalles Bibliográficos
Autores principales: Cleophas, Ton J. (Autor), Zwinderman, Aeilko H. (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: eBook
Lenguaje:English
Publicado: Cham : Springer International Publishing : Imprint: Springer, 2015.
Edición:1st ed. 2015.
Materias:
Tabla de Contenidos:
  • Preface. Section I Cluster and Classification Models
  • Hierarchical Clustering and K-means Clustering to Identify Subgroups in Surveys (50 Patients)
  • Density-based Clustering to Identify Outlier Groups in Otherwise Homogeneous Data (50 Patients)
  • Two Step Clustering to Identify Subgroups and Predict Subgroup Memberships in Individual Future Patients (120 Patients)- Nearest Neighbors for Classifying New Medicines (2 New and 25 Old Opioids)- Predicting High-Risk-Bin Memberships (1445 Families)
  • Predicting Outlier Memberships (2000 Patients)
  • Data Mining for Visualization of Health Processes (150 Patients)
  • 8 Trained Decision Trees for a More Meaningful Accuracy (150 Patients)
  • Typology of Medical Data (51 Patients)
  • Predictions from Nominal Clinical Data (450 Patients)
  • Predictions from Ordinal Clinical Data (450 Patients)
  • Assessing Relative Health Risks (3000 Subjects)
  • Measurement Agreements (30 Patients)
  • Column Proportions for Testing Differences between Outcome Scores (450 Patients)
  • Pivoting Trays and Tables for Improved Analysis of Multidimensional Data (450 Patients)
  • Online Analytical Procedure Cubes for a More Rapid Approach to Analyzing Frequencies (450 Patients)
  • Restructure Data Wizard for Data Classified the Wrong Way (20 Patients).- Control Charts for Quality Control of Medicines (164 Tablet Disintegration Times)
  • Section II (Log) Linear Models
  • Linear, Logistic, and Cox Regression for Outcome Prediction with Unpaired Data (20, 55, and 60 Patients).- Generalized Linear Models for Outcome Prediction with Paired Data (100 Patients and 139 Physicians)
  • Generalized Linear Models for Predicting Event-Rates (50 Patients).- Factor Analysis and Partial Least Squares (PLS) for Complex-Data Reduction (250 Patients)
  • Optimal Scaling of High-sensitivity Analysis of Health Predictors (250 Patients)
  • Discriminant Analysis for Making a Diagnosis from Multiple Outcomes (45 Patients)
  • Weighted Least Squares for Adjusting Efficacy Data with Inconsistent Spread (78 Patients)
  • Partial Correlations for Removing Interaction Effects from Efficacy Data (64 Patients)
  • Canonical Regression for Overall Statistics of Multivariate Data (250 Patients)
  • Multinomial Regression for Outcome Categories (55 Patients)
  • Various Methods for Analyzing Predictor Categories (60 and 30 Patients)
  • Random Intercept Models for Both Outcome and Predictor Categories (55 Patients).- Automatic Regression for Maximizing Linear Relationships (55 Patients)
  • Simulation Models for Varying Predictors (9000 Patients)
  • Generalized Linear Mixed Models for Outcome Prediction from Mixed Data (20 Patients)
  • Two Stage Least Squares for Linear Models with Problematic Predictors (35 Patients)
  • Autoregressive Models for Longitudinal Data (120 Monthly Population Records)
  • Variance Components for Assessing the Magnitude of Random Effects (40 Patients)
  • Ordinal Scaling for Clinical Scores with Inconsistent Intervals (900 Patients)
  • Loglinear Models for Assessing Incident Rates with Varying Incident Risks (12 Populations).- Loglinear Models for Outcome Categories (445 Patients)
  • Heterogeneity in Clinical Research: Mechanisms Responsible (20 Studies)
  • Performance Evaluation of Novel Diagnostic Tests (650 and 588 Patients).- Quantile - Quantile Plots, a Good Start for Looking at Your Medical Data (50 Cholesterol Measurements and 52 Patients)
  • Rate Analysis of Medical Data Better than Risk Analysis (52 Patients)
  • Trend Tests Will Be Statistically Significant if Traditional Tests Are not (30 and 106 Patients)
  • Doubly Multivariate Analysis of Variance for Multiple Observations from Multiple Outcome Variables (16 Patients)
  • Probit Models for Estimating Effective Pharmacological Treatment Dosages (14 Tests)
  • Interval Censored Data Analysis for Assessing Mean Time to Cancer Relapse (51 Patients).- Structural Equation Modeling with SPSS Analysis of Moment Structures (Amos) for Cause Effect Relationships I (35 Patients)
  • Structural Equation Modeling with SPSS Analysis of Moment Structures (Amos) for Cause Effect Relationships II (35 Patients)
  • Section III Rules Models
  • Neural Networks for Assessing Relationships that are Typically Nonlinear (90 Patients). Complex Samples Methodologies for Unbiased Sampling (9,678 Persons)
  • Correspondence Analysis for Identifying the Best of Multiple Treatments in Multiple Groups (217 Patients)
  • Decision Trees for Decision Analysis (1004 and 953 Patients).-Multidimensional Scaling for Visualizing Experienced Drug Efficacies (14 Pain-killers and 42 Patients)
  • Stochastic Processes for Long Term Predictions from Short Term Observations
  • Optimal Binning for Finding High Risk Cut-offs (1445 Families).- Conjoint Analysis for Determining the Most Appreciated Properties of Medicines to Be Developed (15 Physicians)
  • Item Response Modeling for Analyzing Quality of Life with Better Precision (1000 Patients)
  • Survival Studies with Varying Risks of Dying (50 and 60 Patients)
  • Fuzzy Logic for Improved Precision of Pharmacological Data Analysis (9 Induction Dosages)
  • Automatic Data Mining for the Best Treatment of a Disease (90 Patients)
  • Pareto Charts for Identifying the Main Factors of Multifactorial Outcomes (2000 Admissions to Hospital)
  • Radial Basis Neural Networks for Multidimensional Gaussian Data (90 persons)
  • Automatic Modeling for Drug Efficacy Prediction (250 Patients)
  • Automatic Modeling for Clinical Event Prediction (200 Patients)
  • Automatic Newton Modeling in Clinical Pharmacology (15 Alfentanil dosages, 15 Quinidine time-concentration relationships)
  • Spectral Plots for High Sensitivity Assessment of Periodicity (6 Years’ Monthly C Reactive Protein Levels)
  • Runs Test for Identifying Best Analysis Models (21 Estimates of Quantity and Quality of Patient Care)
  • Evolutionary Operations for Health Process Improvement (8 Operation Room Settings).- Bayesian Networks for Cause Effect Modeling (600 Patients)
  • Support Vector Machines for Imperfect Nonlinear Data
  •  Multiple Response Sets for Visualizing Clinical Data Trends (811 Patient Visits)
  • Protein and DNA Sequence Mining
  • Iteration Methods for Crossvalidation (150 Patients)
  • Testing Parallel-groups with Different Sample Sizes and Variances (5 Parallel-group Studies)
  • Association Rules between Exposure and Outcome (50 and 60 Patients)
  • Confidence Intervals for Proportions and Differences in Proportions (100 and 75 Patients)
  • Ratio Statistics for Efficacy Analysis of New Drugs 50 Patients).- Fifth Order Polynomes of Circadian Rhythms (1 Patient)
  • Gamma Distribution for Estimating the Predictors of Medical Outcomes (110 Patients) Index.